All Stories

  1. Risk of secondary osteoporosis in primary biliary cholangitis

    Article • Journal of Gastroenterology and Hepatology, August 2017, Wiley

    hirokazu miyatake

  2. Long-term Combined Therapy with Very-low-dose Peginterferon and Ursodeoxycholic Acid Decreased the Spleen Size in a Patient with Hepatitis C Virus-related Cirrhosis

    Article • Internal Medicine, January 2013, Japanese Society of Internal Medicine

    hirokazu miyatake

  3. Effect of Previous Interferon Treatment on Outcome After Curative Treatment for Hepatitis C Virus-Related Hepatocellular Carcinoma

    Article • Digestive Diseases and Sciences, October 2011, Springer Science + Business Media

    hirokazu miyatake

  4. Partial Splenic Embolization Facilitates the Adherence to Peginterferon in Chronic Hepatitis C with Thrombocytopenia

    Article • Internal Medicine, January 2011, Japanese Society of Internal Medicine

    hirokazu miyatake

  5. Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma

    Article • International Journal of Clinical Oncology, December 2010, Springer Science + Business Media

    hirokazu miyatake

  6. Large Waist Circumference Is a Risk Factor for Reflux Esophagitis in Japanese Males

    Article • Digestion, January 2010, Karger Publishers

    hirokazu miyatake

  7. A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B

    Article • World Journal of Gastroenterology, January 2009, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    hirokazu miyatake

  8. Churg-Strauss Syndrome with Pleural Involvement.

    Article • Internal Medicine, January 2000, Japanese Society of Internal Medicine

    hirokazu miyatake

  9. Pulmonary Lymphangiomyomatosis (LAM) Developing Chylothorax.

    Article • Internal Medicine, January 2000, Japanese Society of Internal Medicine

    hirokazu miyatake